Tag: Resistance
-

OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ — OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product’s potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetrati…
-

EMPE Diagnostics to Unveil CircuLOK Product Range at NATCON 2026, Expanding Access to TB Drug-Resistance Diagnostics
STOCKHOLM, Sept. 10, 2026 /PRNewswire/ — EMPE Diagnostics AB today announced it will unveil the CircuLOK product range at the 81st National Conference on Tuberculosis and Chest Diseases (NATCON 2026), taking place 1–4 October in Patiala, India. The launch expands EMPE’s TB molecular resistance-test…










